Emmaus Life Sciences, Inc.
EMMA
$0.01
$0.000.99%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.13M | 293.00K | 886.00K | 1.33M | 1.39M |
| Total Receivables | 2.80M | 2.62M | 2.07M | 2.06M | 2.62M |
| Inventory | 1.56M | 1.21M | 1.31M | 1.44M | 1.64M |
| Prepaid Expenses | 901.00K | 346.00K | 525.00K | 611.00K | 894.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 359.00K | 315.00K | 220.00K | 211.00K | 226.00K |
| Total Current Assets | 7.75M | 4.79M | 5.02M | 5.65M | 6.77M |
|
|
|||||
| Total Current Assets | 7.75M | 4.79M | 5.02M | 5.65M | 6.77M |
| Net Property, Plant & Equipment | 879.00K | 927.00K | 973.00K | 1.37M | 1.58M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 207.00K | 167.00K | 168.00K | 222.00K | 222.00K |
| Total Assets | 21.44M | 20.76M | 23.34M | 22.48M | 23.60M |
|
|
|||||
| Total Accounts Payable | 282.00K | 724.00K | 750.00K | 520.00K | 594.00K |
| Total Accrued Expenses | 25.52M | 24.54M | 21.62M | 22.89M | 21.33M |
| Short-term Debt | 11.15M | 10.77M | 11.40M | 10.64M | 10.47M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.73M | 17.15M | 17.15M | 19.54M | 19.44M |
| Total Finance Division Other Current Liabilities | 14.39M | 10.99M | 11.15M | 11.32M | 11.73M |
| Total Other Current Liabilities | 14.39M | 10.99M | 11.15M | 11.32M | 11.73M |
| Total Current Liabilities | 69.07M | 64.17M | 62.08M | 64.92M | 63.56M |
|
|
|||||
| Total Current Liabilities | 69.07M | 64.17M | 62.08M | 64.92M | 63.56M |
| Long-Term Debt | 2.27M | 2.26M | 2.26M | 2.25M | 2.25M |
| Short-term Debt | 11.15M | 10.77M | 11.40M | 10.64M | 10.47M |
| Capital Leases | 1.41M | 1.50M | 1.58M | 544.00K | 815.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.29M | 12.31M | 13.13M | 13.37M | 13.47M |
| Total Liabilities | 85.04M | 80.24M | 79.05M | 81.08M | 80.08M |
|
|
|||||
| Common Stock & APIC | 226.06M | 225.98M | 225.97M | 225.97M | 225.96M |
| Retained Earnings | -270.07M | -268.12M | -266.04M | -264.91M | -262.58M |
| Treasury Stock & Other | -19.60M | -17.35M | -15.63M | -19.67M | -19.86M |
| Total Common Equity | -63.61M | -59.49M | -55.70M | -58.60M | -56.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -63.61M | -59.49M | -55.70M | -58.60M | -56.48M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -63.61M | -59.49M | -55.70M | -58.60M | -56.48M |
|
|
|||||